"Laughing Gas" Is Not Funny If You Have MTHFR

Nitrous oxide — laughing gas — is used routinely in dental procedures, minor surgeries, and increasingly as a recreational substance. For most people, exposure is brief and without lasting consequence. But for people with MTHFR gene variants, a single significant exposure to nitrous oxide can trigger a serious and potentially lasting B12 deficiency syndrome — and in some cases, a neurological crisis.

How Nitrous Oxide Affects B12

Nitrous oxide irreversibly oxidises cobalt in vitamin B12, converting it from its active cobalamin form to an inactive compound. This effectively destroys B12 function in every cell it reaches. For most people with normal B12 stores and no genetic vulnerability, a single dental procedure is unlikely to cause lasting problems — the body's B12 reserves are sufficient to compensate.

For people with MTHFR variants, the picture is more complex. MTHFR impairment already compromises the methylation cycle's efficiency. The B12 destroyed by nitrous oxide exposure may represent a significant proportion of an already-limited functional reserve. And the methylation reactions most dependent on B12 — including homocysteine remethylation — are precisely the ones most vulnerable in people with MTHFR variants.

The Clinical Consequence: Subacute Combined Degeneration

In the most serious cases, nitrous oxide-induced B12 depletion in vulnerable individuals can trigger subacute combined degeneration of the spinal cord — a neurological syndrome characterised by progressive damage to the posterior and lateral columns of the spinal cord. Symptoms include tingling, numbness, weakness, and in severe cases, difficulty walking and spasticity. This is more likely in people with pre-existing low B12 status and MTHFR variants who receive prolonged or repeated nitrous oxide exposure.

What to Do Before Dental or Surgical Procedures

If you have MTHFR variants, inform your dentist or anaesthetist before any procedure involving nitrous oxide. Request an alternative anaesthetic or analgesic where possible. Ensure your B12 status is optimal before elective procedures — supplementing with methylcobalamin in the weeks before a procedure is a reasonable precaution. After significant nitrous oxide exposure, retest B12 and homocysteine levels within four to six weeks.

NeuroThrive™ products are food supplements and are not intended to diagnose, treat, or cure any medical condition. If you have concerns about nitrous oxide exposure and MTHFR, discuss them with your GP or anaesthetist.